| Financial Year |
March 31 2023 |
| Monetary Funds |
655,216,233.28 |
| Held-for-trading Financial Assets |
352,278,345.73 |
| Notes Receivable |
-- |
| Accounts Receivable |
351,004,304.97 |
| Advances to Suppliers |
118,654,562.24 |
| Other Receivables |
6,696,012.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,198,263,116.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
89,265,825.95 |
| Total Current Assets |
2,906,937,401.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
121,426,273.92 |
| Investment Properties |
27,957,016.36 |
| Fixed Assetes |
583,239,188.82 |
| Under-construction Projects |
58,067,220.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,483,591.83 |
| R&D expenses |
-- |
| Goodwill |
24,362,924.17 |
| Long-Term Deferred and Prepaid Expenses |
2,188,956.79 |
| Deferred Income Tax Assets |
28,990,390.07 |
| Other Non-Current Assets |
54,355,508.70 |
| Sub-Total of Non-Current Assets |
1,024,411,833.47 |
| Total Assets |
3,931,349,234.97 |
| Short-Term Loans |
455,685,638.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
21,242,287.55 |
| Accounts Payable |
277,394,471.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,664,751.50 |
| Taxes Payable |
27,901,342.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
109,724,348.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
311,736,219.60 |
| Other Current Liabilities |
25,731,294.57 |
| Sub-Total of Current Liabilities |
1,272,454,338.36 |
| Long-term Loans |
77,283,554.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,368,241.08 |
| Deferred Income Tax Liabilities |
26,206,635.62 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
135,683,426.44 |
| Total Liabilities |
1,408,137,764.80 |
| Paid-In Capital(Or Share Stock) |
291,862,944.00 |
| Capital Surplus |
1,266,748,214.10 |
| Surplus Reserve |
148,277,721.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
655,034,540.90 |
| Minority Stockholder's Interest |
144,721,974.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,378,489,495.19 |
| Owner's Equity（Stockholder's Equity） |
2,523,211,470.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,931,349,234.97 |
